Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma.
about
Adamantinoma: a clinicopathological review and updateDurable remissions are rare following high dose therapy with autologous stem cell transplantation for adults with "paediatric" bone and soft tissue sarcomasThe endochondral bone protein CHM1 sustains an undifferentiated, invasive phenotype, promoting lung metastasis in Ewing sarcoma.High-dose therapy with stem cell rescue for pediatric solid tumors: rationale and results.Lymphokines post autologous peripheral blood stem cell transplantation in children.Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma.Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomasIncidence and prognostic value of tumour cells detected by RT-PCR in peripheral blood stem cell collections from patients with Ewing tumour.A Phase II Study of Docetaxel in Patients with Relapsed and Refractory Ewing's Tumours.EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells.Myeloablative therapy against high risk Ewing's sarcoma: A single institution experience and literature reviewBone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow.Treatment of an Askin tumor: A case report and review of the literature.Multimodality image guided total marrow irradiation and verification of the dose delivered to the lung, PTV, and thoracic bone in a patient: a case study.Outcome in 43 children presenting with metastatic Ewing sarcoma: the St. Jude Children's Research Hospital experience, 1962 to 1992.The molecular pathology of small round-cell tumours--relevance to diagnosis, prognosis, and classification.Metastatic Ewing's Sarcoma: Revisiting the "Evidence on the Fence".Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificity.High-dose busulfan and melphalan as conditioning regimen for autologous peripheral blood progenitor cell transplantation in high-risk ewing sarcoma patients: a long-term follow-up single-center study.Induction of a CD3+/CD56+ lymphocyte population following gene therapy with transgenic IL-2 secreting fibroblasts in a child with peripheral neuroectodermal malignancy.Escalating topotecan in combination with treosulfan has acceptable toxicity in advanced pediatric sarcomas.Successful collection of peripheral blood stem cells upon VIDE chemomobilization in sarcoma patients.Autologous stem cell transplantation for high-risk Ewing's sarcoma and other pediatric solid tumors.Role of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation for Children and Young Adults with Relapsed Ewing's Sarcoma: A Systematic Review.Precision medicine in pediatric oncologyHigh-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008
P2860
Q21203676-F1C63EFF-5468-486D-9F36-7AE321D1E31CQ24814364-33485CD7-C30A-453D-8C13-957D0C87D5F4Q30313322-DFF5D316-1501-4B93-BE31-9C08DEC7DD2BQ33788214-A9DC9448-13CE-4AAA-8571-9E8792FF94D9Q33847106-972F4361-2679-41E0-98B0-7156DD163193Q35190216-F0B085B0-151F-4879-860A-43FA95E3326AQ35683306-4A86B0B4-08B5-43A6-A8AF-A39395B6C618Q36611954-05BF2C3C-DFEA-4E4E-A26F-B376E0408610Q36674217-FB0F458B-612A-4F56-A127-38890224C1BBQ37362452-2B5F8380-E691-4217-824C-EBB06CD98AF2Q37392265-CA2FF1B1-806D-4EB4-B4A2-36074C2F068EQ37688646-C4DCCC04-8CAB-4012-85AE-2BEC850BC8F1Q38153701-43907775-08E3-4383-9219-855D69603F10Q40007918-055C5799-EFF9-4862-9EF9-A470FAF03579Q40936630-A53D1B32-5801-4950-9EDC-C47DEC2D4682Q41017883-1683AAF1-B280-4066-9333-A5ABE7C2229DQ41601821-2C6293AC-E393-42D7-AB8F-E7507E51F4C5Q41817126-40F6A5E9-6BAD-4D2E-B330-84D0F3A95090Q43082436-91461F80-046F-49A6-ACFD-73946CC05E1AQ45888529-53CF919F-58C8-43D2-B706-FEF5C4349442Q45911250-7E1335BE-C670-41AC-ABB1-4877C49C621BQ48015098-33F8E194-C098-4913-B104-0C6952B32E0AQ53650236-C0FA2F8A-1A9B-421F-B660-09F491753140Q55426535-A32C9251-C7B4-4C48-8412-51964F4BD54CQ57384544-E37F28FA-DC44-4029-A30C-2A8EE6EF614BQ58760461-7A137216-59FA-4C80-9839-9611FAED7231
P2860
Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Myeloablative radiochemotherap ...... oor-prognosis Ewing's sarcoma.
@en
Myeloablative radiochemotherap ...... oor-prognosis Ewing's sarcoma.
@nl
type
label
Myeloablative radiochemotherap ...... oor-prognosis Ewing's sarcoma.
@en
Myeloablative radiochemotherap ...... oor-prognosis Ewing's sarcoma.
@nl
prefLabel
Myeloablative radiochemotherap ...... oor-prognosis Ewing's sarcoma.
@en
Myeloablative radiochemotherap ...... oor-prognosis Ewing's sarcoma.
@nl
P2093
P1476
Myeloablative radiochemotherap ...... oor-prognosis Ewing's sarcoma.
@en
P2093
C Mauz-Körholz
E Koscielniak
M Paulussen
W Nürnberger
P304
P356
10.1200/JCO.1993.11.8.1482
P407
P577
1993-08-01T00:00:00Z